S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   313.83 (+0.32%)
AAPL   121.53 (+0.45%)
MSFT   232.41 (+1.49%)
FB   257.47 (+1.09%)
GOOGL   2,019.94 (+0.20%)
AMZN   3,093.00 (+1.17%)
TSLA   673.71 (-1.25%)
NVDA   547.40 (+2.84%)
BABA   237.76 (-1.01%)
CGC   33.01 (-0.60%)
GE   12.53 (-1.80%)
MU   91.55 (+3.89%)
NIO   45.79 (-2.18%)
AMD   84.38 (+2.38%)
T   27.96 (-2.34%)
F   11.70 (-0.51%)
ACB   10.55 (-2.50%)
DIS   189.27 (-0.90%)
BA   212.42 (-1.86%)
NFLX   535.51 (-2.05%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   313.83 (+0.32%)
AAPL   121.53 (+0.45%)
MSFT   232.41 (+1.49%)
FB   257.47 (+1.09%)
GOOGL   2,019.94 (+0.20%)
AMZN   3,093.00 (+1.17%)
TSLA   673.71 (-1.25%)
NVDA   547.40 (+2.84%)
BABA   237.76 (-1.01%)
CGC   33.01 (-0.60%)
GE   12.53 (-1.80%)
MU   91.55 (+3.89%)
NIO   45.79 (-2.18%)
AMD   84.38 (+2.38%)
T   27.96 (-2.34%)
F   11.70 (-0.51%)
ACB   10.55 (-2.50%)
DIS   189.27 (-0.90%)
BA   212.42 (-1.86%)
NFLX   535.51 (-2.05%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   313.83 (+0.32%)
AAPL   121.53 (+0.45%)
MSFT   232.41 (+1.49%)
FB   257.47 (+1.09%)
GOOGL   2,019.94 (+0.20%)
AMZN   3,093.00 (+1.17%)
TSLA   673.71 (-1.25%)
NVDA   547.40 (+2.84%)
BABA   237.76 (-1.01%)
CGC   33.01 (-0.60%)
GE   12.53 (-1.80%)
MU   91.55 (+3.89%)
NIO   45.79 (-2.18%)
AMD   84.38 (+2.38%)
T   27.96 (-2.34%)
F   11.70 (-0.51%)
ACB   10.55 (-2.50%)
DIS   189.27 (-0.90%)
BA   212.42 (-1.86%)
NFLX   535.51 (-2.05%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   313.83 (+0.32%)
AAPL   121.53 (+0.45%)
MSFT   232.41 (+1.49%)
FB   257.47 (+1.09%)
GOOGL   2,019.94 (+0.20%)
AMZN   3,093.00 (+1.17%)
TSLA   673.71 (-1.25%)
NVDA   547.40 (+2.84%)
BABA   237.76 (-1.01%)
CGC   33.01 (-0.60%)
GE   12.53 (-1.80%)
MU   91.55 (+3.89%)
NIO   45.79 (-2.18%)
AMD   84.38 (+2.38%)
T   27.96 (-2.34%)
F   11.70 (-0.51%)
ACB   10.55 (-2.50%)
DIS   189.27 (-0.90%)
BA   212.42 (-1.86%)
NFLX   535.51 (-2.05%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:EPIX

ESSA Pharma SEC Filings & 10K Form

$26.88
+1.45 (+5.70 %)
(As of 02/26/2021 03:59 PM ET)
Add
Compare
Today's Range
$25.01
Now: $26.88
$27.04
50-Day Range
$12.02
MA: $19.61
$28.65
52-Week Range
$3.00
Now: $26.88
$32.69
Volume5,089 shs
Average Volume475,042 shs
Market Capitalization$861.88 million
P/E RatioN/A
Dividend YieldN/A
Beta1.96

SEC Filings

ESSA Pharma (NASDAQ:EPIX) SEC Filings

DateFilerForm TypeView
02/22/2021
4:16 PM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
3:58 PM
ESSA Pharma (Filer)
Form 424B5
02/16/2021
8:42 AM
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
ESSA Pharma (Subject)
Form SC 13G
02/16/2021
8:15 AM
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
ESSA Pharma (Subject)
Form SC 13G
02/12/2021
1:32 PM
ESSA Pharma (Subject)
Omega Fund IV, L.P. (Filed by)
Form SC 13G/A
02/11/2021
4:20 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
ESSA Pharma (Subject)
Form SC 13G/A
02/11/2021
9:28 AM
ESSA Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
6:02 AM
ESSA Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/26/2021
6:03 PM
ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
Form 4/A
01/26/2021
6:03 PM
ESSA Pharma (Issuer)
Thorell Marella (Reporting)
Form 4/A
01/26/2021
6:03 PM
ESSA Pharma (Issuer)
Sollis Gary (Reporting)
Form 4/A
01/26/2021
6:02 PM
ESSA Pharma (Issuer)
Requadt Scott (Reporting)
Form 4/A
01/26/2021
6:02 PM
ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
Form 4/A
01/26/2021
6:02 PM
ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
Form 4/A
01/26/2021
6:01 PM
Brettman Ari David (Reporting)
ESSA Pharma (Issuer)
Form 4/A
01/26/2021
6:01 PM
BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
Form 4/A
01/26/2021
3:49 PM
ESSA Pharma (Filer)
Form DEF 14A
01/11/2021
3:47 PM
ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:47 PM
ESSA Pharma (Issuer)
Wood David S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:46 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:46 PM
ESSA Pharma (Issuer)
Thorell Marella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:46 PM
ESSA Pharma (Issuer)
Sollis Gary (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:45 PM
ESSA Pharma (Issuer)
Requadt Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:45 PM
ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:44 PM
ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:44 PM
ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:43 PM
Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:43 PM
Brettman Ari David (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
3:42 PM
BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
12/29/2020
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
12/23/2020
4:22 PM
ESSA Pharma (Filer)
Form S-3/A
12/23/2020
4:21 PM
ESSA Pharma (Filer)
Form S-3/A
11/25/2020
3:37 PM
ESSA Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/25/2020
3:31 PM
ESSA Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2020
3:31 PM
ESSA Pharma (Subject)
Vivo Capital IX, LLC (Filed by)
Form SC 13G
10/02/2020
6:17 PM
ESSA Pharma (Issuer)
ZWEIFACH SANFORD S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2020
6:16 PM
ESSA Pharma (Issuer)
Martin John Alexander (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
6:04 PM
ESSA Pharma (Issuer)
Thorell Marella (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
6:03 PM
Blackstone Clarus III L.L.C. (Reporting)
Blackstone Group Inc (Reporting)
Blackstone Group Management L.L.C. (Reporting)
Blackstone Holdings I/II GP L.L.C. (Reporting)
Blackstone Holdings II L.P. (Reporting)
Clarus Lifesciences III, L.P. (Reporting)
Clarus Ventures III GP, L.P. (Reporting)
ESSA Pharma (Issuer)
SCHWARZMAN STEPHEN A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
6:03 PM
ESSA Pharma (Issuer)
Sollis Gary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:40 PM
Cesano Alessandra (Reporting)
ESSA Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:39 PM
ESSA Pharma (Issuer)
Wood David S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:39 PM
ESSA Pharma (Issuer)
Virsik Peter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:39 PM
Brettman Ari David (Reporting)
ESSA Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:38 PM
BERGER FRANKLIN M (Reporting)
ESSA Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:38 PM
ESSA Pharma (Issuer)
Glickman Richard M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:38 PM
ESSA Pharma (Issuer)
Requadt Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2020
5:37 PM
ESSA Pharma (Issuer)
Parkinson David Ross (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/21/2020
8:40 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2020
4:22 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/14/2020
8:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2020
8:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
11:19 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/03/2020
11:56 AM
ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
Form SC 13G/A
07/29/2020
8:55 PM
ESSA Pharma (Filer)
Form 424B5
07/28/2020
8:48 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2020
3:11 PM
ESSA Pharma (Filer)
Form 424B5
07/15/2020
7:33 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/22/2020
8:17 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2020
7:37 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2020
7:34 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2020
4:31 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/13/2020
4:01 PM
ESSA Pharma (Filer)
Form 424B5
03/31/2020
8:33 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2020
8:09 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2019
7:11 PM
ESSA Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
11/12/2019
1:31 PM
ESSA Pharma (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/05/2019
11:15 PM
ESSA Pharma (Filer)
Form EFFECT
11/05/2019
12:19 PM
ESSA Pharma (Filer)
Form F-3/A
10/30/2019
8:01 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2019
12:02 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2019
2:39 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2019
3:51 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2019
6:10 PM
ESSA Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/07/2019
2:18 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2019
8:38 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2019
10:54 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2019
4:22 PM
Clarus Lifesciences III, L.P. (Filed by)
ESSA Pharma (Subject)
Form SC 13D/A
09/05/2019
12:36 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2019
2:31 PM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13G
08/30/2019
1:01 PM
ESSA Pharma (Filer)
Form D
Notice of Exempt Offering of Securities 
08/29/2019
8:44 AM
ESSA Pharma (Subject)
Soleus Capital, LLC (Filed by)
Form SC 13G
08/27/2019
8:36 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2019
10:56 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2019
7:48 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2019
7:39 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2019
7:51 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2019
8:50 AM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13D/A
07/15/2019
8:10 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/08/2019
3:37 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2019
8:34 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2019
8:18 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2019
7:42 PM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2019
10:44 AM
ESSA Pharma (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Form SC 13D
05/16/2019
9:05 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2019
7:00 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2019
7:12 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2019
9:02 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2019
7:59 AM
ESSA Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.